SharonAI Holdings heads into July with a striking split: short sellers have been unwinding positions rapidly, yet the cost to borrow the stock has nearly doubled in a month.
The lending market tells the clearest story this week. Borrow costs have surged to 14.6%, up 47% over the past week and almost double the level from a month ago. That rise is happening even as the number of shares short has collapsed — down 75% over the week alone, from roughly 4.6 million shares in mid-June to just over one million now. The borrow market remains extremely tight. Availability has been near zero for most of the past two weeks, hitting a low of just 0.002% on June 23 before edging up to 31% on June 30 as some positions were returned to the lending pool. Put differently, for much of June there was barely a share left to borrow against the stock. The combination of rising cost and falling short interest points to a squeeze-driven unwind rather than bears voluntarily stepping away — the shorts have been forced out, not persuaded out.
Options positioning reinforces the bullish tilt. The put/call ratio has collapsed from a 52-week high of 0.75 in mid-June to just 0.20 this week. That's a dramatic shift: two weeks ago options traders were carrying their heaviest downside hedges of the past year; now calls dominate overwhelmingly. The ORTEX short score has also eased from a peak near 81 on June 18-19 to 71 today, still elevated but moving in the right direction for longs.
Analyst coverage is thin and dated for a stock now trading at $84.66. Three initiations — from Compass Point, Lucid Capital Markets, and Cantor Fitzgerald — all landed in April with Buy or Overweight ratings, but targets ranged from $40 to $50. Those targets are now roughly half the current price, suggesting either the Street hasn't caught up or the recent run has outpaced fundamentals materially. The mean target of $105 reflects some upward revision but still implies coverage remains sparse and stale. The valuation picture is complicated: the company carries a negative earnings yield and a negative P/E, reflecting an unprofitable business. The EV/EBITDA multiple has compressed 30% over the past month to 3.4x, which looks optically cheap but may reflect deteriorating near-term profitability rather than a genuine re-rating.
Ownership is concentrated and active. Three individual holders — James Manning, Andrew Leece, and Nicholas Hughes-Jones — collectively control about 25% of shares between them. Millennium Management entered as a significant holder in early April with a near-full build of its current 870,000-share position. Several smaller hedge funds also disclosed new positions in Q1. Insider data on file is stale, dating to mid-2023, so it offers no read on recent management sentiment.
The most recent earnings event, a June 23 release, saw the stock fall 8.9% the next day and lose 7.9% over the following week. The prior event in May produced the opposite: a 3.4% gain on the day and a 22% rally over five days. The next print is due August 14, and the wide range of post-earnings outcomes — from -9% to +22% — makes positioning into that date the most important variable to track as availability in the lending market either normalises or tightens again.
See the live data behind this article on ORTEX.
Open SHAZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
